Read More: eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney
eGenesis Appoints Dr. Jay Barth as Chief Medical Officer
eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure
eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient
eGenesis and PorMedTec Announce Successful Production of Genetically Engineered Porcine Donors in Japan
eGenesis and OrganOx Announce Successful Use of a Genetically Engineered Porcine Liver with a Human Donor
eGenesis Presents Preclinical Data Demonstrating Recipient Survival and Compatibility with Genetically Engineered Porcine Kidneys at 2023 IPITA-IXA-CTRMS Joint Conference
eGenesis Announces Publication in Nature of Landmark Preclinical Data Demonstrating Long-Term Survival with Genetically Engineered Porcine Kidneys